Tamás Garay

1.1k total citations
36 papers, 712 citations indexed

About

Tamás Garay is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Tamás Garay has authored 36 papers receiving a total of 712 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 20 papers in Oncology and 5 papers in Cell Biology. Recurrent topics in Tamás Garay's work include Melanoma and MAPK Pathways (10 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Cellular Mechanics and Interactions (4 papers). Tamás Garay is often cited by papers focused on Melanoma and MAPK Pathways (10 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Cellular Mechanics and Interactions (4 papers). Tamás Garay collaborates with scholars based in Hungary, Austria and Germany. Tamás Garay's co-authors include Balázs Hegedűs, Walter Berger, Michael Grusch, Balázs Döme, József Tóvári, József Tı́már, Eszter Molnár, András Czirók, Viktória László and Walter Klepetko and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Tamás Garay

34 papers receiving 710 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tamás Garay Hungary 18 332 237 112 92 90 36 712
Paul‐Joseph Aspuria United States 13 547 1.6× 242 1.0× 84 0.8× 197 2.1× 115 1.3× 22 808
Nawal Bendris United States 13 477 1.4× 181 0.8× 212 1.9× 118 1.3× 74 0.8× 16 686
Jianhua Chen China 15 376 1.1× 132 0.6× 54 0.5× 116 1.3× 53 0.6× 33 630
Liliana Krasińska France 12 561 1.7× 234 1.0× 235 2.1× 135 1.5× 96 1.1× 18 910
Laura Rodríguez de la Ballina Norway 12 455 1.4× 134 0.6× 149 1.3× 143 1.6× 37 0.4× 18 848
Chunhua Yan United States 16 459 1.4× 205 0.9× 59 0.5× 162 1.8× 60 0.7× 35 773
Chun-Hau Chen United States 13 833 2.5× 354 1.5× 132 1.2× 127 1.4× 63 0.7× 13 1.1k
Ivanka Kovalyshyn United States 8 589 1.8× 588 2.5× 123 1.1× 186 2.0× 49 0.5× 16 1.0k
Mona L. Gauthier United States 18 591 1.8× 426 1.8× 107 1.0× 321 3.5× 103 1.1× 18 1.1k
Xiong Jin South Korea 20 630 1.9× 299 1.3× 61 0.5× 275 3.0× 125 1.4× 42 1.1k

Countries citing papers authored by Tamás Garay

Since Specialization
Citations

This map shows the geographic impact of Tamás Garay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamás Garay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamás Garay more than expected).

Fields of papers citing papers by Tamás Garay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamás Garay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamás Garay. The network helps show where Tamás Garay may publish in the future.

Co-authorship network of co-authors of Tamás Garay

This figure shows the co-authorship network connecting the top 25 collaborators of Tamás Garay. A scholar is included among the top collaborators of Tamás Garay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamás Garay. Tamás Garay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garay, Tamás, Magdolna Herold, Alexandra Simon, et al.. (2024). Immune Marker and C-Reactive Protein Dynamics and Their Prognostic Implications in Modulated Electro-Hyperthermia Treatment in Advanced Pancreatic Cancer: A Retrospective Analysis. SHILAP Revista de lepidopterología. 4(4). 385–399. 1 indexed citations
2.
Varga, Zoltán, Edit I. Buzás, Delaram Khamari, et al.. (2024). Extracellular vesicles promote migration despite BRAF inhibitor treatment in malignant melanoma cells. Cell Communication and Signaling. 22(1). 282–282.
3.
Herold, Zoltán, Tamás Garay, Magdolna Herold, et al.. (2023). High Tumor-Infiltrating Lymphocyte Count Is Associated with Distinct Gene Expression Profile and Longer Patient Survival in Advanced Ovarian Cancer. International Journal of Molecular Sciences. 24(18). 13684–13684. 3 indexed citations
4.
Hegedüs, Luca, Verena Jendrossek, Samuel Peña‐Llopis, et al.. (2022). Nintedanib and Dasatinib Treatments Induce Protective Autophagy as a Potential Resistance Mechanism in MPM Cells. Frontiers in Cell and Developmental Biology. 10. 852812–852812. 8 indexed citations
5.
Molnár, Eszter, Tamás Garay, Luca Hegedüs, et al.. (2020). Horizontal Combination of MEK and PI3K/mTOR Inhibition in BRAF Mutant Tumor Cells with or without Concomitant PI3K Pathway Mutations. International Journal of Molecular Sciences. 21(20). 7649–7649. 6 indexed citations
6.
Molnár, Eszter, Senji Shirasawa, I. Jalsovszky, et al.. (2020). Next Generation Lipophilic Bisphosphonate Shows Antitumor Effect in Colorectal Cancer In Vitro and In Vivo. Pathology & Oncology Research. 26(3). 1957–1969. 12 indexed citations
7.
Reck, Martin, Delvys Rodríguez‐Abreu, Rina Hui, et al.. (2019). OA14.01 KEYNOTE-024 3-Year Survival Update: Pembrolizumab vs Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 14(10). S243–S243. 29 indexed citations
8.
Ladányi, Andrea, et al.. (2019). Selective Inhibition of HIF1α Expression by ZnSO4 Has Antitumoral Effects in Human Melanoma. Pathology & Oncology Research. 26(2). 673–679. 4 indexed citations
9.
Molnár, Eszter, Tamás Garay, Marco Donia, et al.. (2019). Long-Term Vemurafenib Exposure Induced Alterations of Cell Phenotypes in Melanoma: Increased Cell Migration and Its Association with EGFR Expression. International Journal of Molecular Sciences. 20(18). 4484–4484. 23 indexed citations
10.
László, Viktória, Ildikó Kovács, Mir Alireza Hoda, et al.. (2018). Nintedanib Is Active in Malignant Pleural Mesothelioma Cell Models and Inhibits Angiogenesis and Tumor Growth In Vivo. Clinical Cancer Research. 24(15). 3729–3740. 25 indexed citations
11.
Oien, Derek B., et al.. (2018). Cisplatin and Pemetrexed Activate AXL and AXL Inhibitor BGB324 Enhances Mesothelioma Cell Death from Chemotherapy. Frontiers in Pharmacology. 8. 970–970. 28 indexed citations
12.
László, Viktória, Ildikó Kovács, Tamás Garay, et al.. (2018). The FAK inhibitor BI 853520 inhibits spheroid formation and orthotopic tumor growth in malignant pleural mesothelioma. Journal of Molecular Medicine. 97(2). 231–242. 34 indexed citations
13.
Molnár, Eszter, Michael Grusch, Walter Berger, et al.. (2018). Pan-RAF and MEK vertical inhibition enhances therapeutic response in non-V600 BRAF mutant cells. BMC Cancer. 18(1). 542–542. 19 indexed citations
14.
Кузнецова, И. Л., Thomas Aschacher, Balázs Hegedűs, et al.. (2017). Targeting an Oncolytic Influenza A Virus to Tumor Tissue by Elastase. Molecular Therapy — Oncolytics. 7. 37–44. 12 indexed citations
15.
Hegedüs, Luca, Rita Padányi, Mária Judit Molnár, et al.. (2017). Histone Deacetylase Inhibitor Treatment Increases the Expression of the Plasma Membrane Ca2+ Pump PMCA4b and Inhibits the Migration of Melanoma Cells Independent of ERK. Frontiers in Oncology. 7. 95–95. 23 indexed citations
16.
Szabó, Attila, Tünde Fekete, Gábor Koncz, et al.. (2016). RIG-I inhibits the MAPK-dependent proliferation of BRAF mutant melanoma cells via MKP-1. Cellular Signalling. 28(5). 335–347. 21 indexed citations
17.
Garay, Tamás, Eszter Molnár, Éva Juhász, et al.. (2015). Sensitivity of Melanoma Cells to EGFR and FGFR Activation but Not Inhibition is Influenced by Oncogenic BRAF and NRAS Mutations. Pathology & Oncology Research. 21(4). 957–968. 9 indexed citations
18.
Garay, Tamás, István Kenessey, Eszter Molnár, et al.. (2015). Prenylation Inhibition-Induced Cell Death in Melanoma: Reduced Sensitivity in BRAF Mutant/PTEN Wild-Type Melanoma Cells. PLoS ONE. 10(2). e0117021–e0117021. 20 indexed citations
19.
Berta, Judit, Mir Alireza Hoda, Viktória László, et al.. (2014). Apelin promotes lymphangiogenesis and lymph node metastasis. Oncotarget. 5(12). 4426–4437. 75 indexed citations
20.
Garay, Tamás, et al.. (2005). The use of the reed (Phragmites australis) in wastewater treatment on constructed wetlands. Acta Biologica Szegediensis. 49. 81–83. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul‐Joseph Aspuria Breakdown of academic impact, for papers by Nawal Bendris Breakdown of academic impact, for papers by Jianhua Chen Breakdown of academic impact, for papers by Liliana Krasińska Breakdown of academic impact, for papers by Laura Rodríguez de la Ballina Breakdown of academic impact, for papers by Chunhua Yan Breakdown of academic impact, for papers by Chun-Hau Chen Breakdown of academic impact, for papers by Ivanka Kovalyshyn Breakdown of academic impact, for papers by Mona L. Gauthier Breakdown of academic impact, for papers by Xiong Jin
Rankless by CCL
2026